Skip to main content
Ivan Maillard, MD, Hematology, New York, NY

Ivan Patrick Maillard MD PhD

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology


Professor of Medicine and Vice-Chief for Research, Division of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine

Request Appointment
  • 1275 York AvenueNew York, NY 10065

  • Book by Phone+1(629) 306-9414

Overview of  Dr. Maillard

Dr. Ivan Maillard is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Hospital of the University of Pennsylvania. He received his medical degree from University of Lausanne Faculty of Medicine and has been in practice 24 years. Dr. Maillard accepts several types of health insurance, listed below. He is one of 38 doctors at Hospital of the University of Pennsylvania and one of 71 doctors at Memorial Sloan Kettering Cancer Center who specialize in Hematology. He also speaks multiple languages, including French, German, and Portuguese. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2001 - 2005
  • University of Lausanne Faculty of Medicine
    University of Lausanne Faculty of MedicineClass of 1993

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2024 - 2026
  • PA State Medical License
    PA State Medical License 2001 - 2024
  • MI State Medical License
    MI State Medical License 2007 - 2020
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-Exposure SARS-CoV-2 Prophylaxis Among Health Care Workers  
    Matthew C Hyman, Ian Frank, Scott E Hensley, Saar Gill, Dan T Vogl, Ivan Maillard, Daria V Babushok, Alexander C Huang, Sunita D Nasta, Jennifer C Walsh, Michael C Mil..., JAMA Internal Medicine
  • The FOSSIL Study: FLAG or Standard 7+3 Induction Therapy in Secondary Acute Myeloid Leukemia  
    Dale L Bixby, Ivan P Maillard, Moshe Talpaz, Leukemia Research
  • Notch Signaling Mediated by Delta-like1/4 Ligands Controls the Pathogenesis of Chronic Graft-Versus-Host Disease in Mice  
    Ivan Maillard, Eric T Perkey, Maria A Pletneva, Stefanie Sarantopoulos, Bruce R Blazar, Vedran Radojcic, Blood
  • Join now to see all

Abstracts/Posters

  • Dll1 and Dll4 Notch Ligands Prime T Cell Alloimmunity and Are Expressed in Non-Overlapping Populations of Fibroblastic Stromal Cells in Spleen and Lymph Nodes at the O...
    Ivan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
    Ivan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • SETDB1 Mediated H3K9 Methylation Suppresses MLL-Fusion Target Expression and Leukemic Transformation
    Ivan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Stromal Cell Immune Regulation in the Microenvironment 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • The PAF1c Subunit Cdc73 Is Essential for Hematopoiesis and Displays Differential Gene Regulation in MLL-AF9 Driven Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Pharmacologic Blockade of Notch/Delta-like Ligand 4 Signaling Protects from Gastrointestinal Acute Graft-Versus-Host Disease in Non-Human Primates 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Authored Content

  • The FOSSIL Study: FLAG or Standard 7+3 Induction Therapy in Secondary Acute Myeloid LeukemiaJune 2018

Press Mentions

  • A Crucial Mechanism in Immune Response: NOTCH Signaling Pathway Plays Essential Role in CD8⁺ T Cell Differentiation
    A Crucial Mechanism in Immune Response: NOTCH Signaling Pathway Plays Essential Role in CD8⁺ T Cell DifferentiationMarch 25th, 2025
  • Montreal Study Provides Insight into How T Lymphocytes Work
    Montreal Study Provides Insight into How T Lymphocytes WorkMarch 20th, 2025
  • Genome Toxicity and Impaired Stem Cell Function After Conditional Activation of CreERT2 in the Intestine
    Genome Toxicity and Impaired Stem Cell Function After Conditional Activation of CreERT2 in the IntestineNovember 15th, 2018
  • Join now to see all

Professional Memberships

Other Languages

  • French, German, Portuguese

Insurance Accepted

  • Aetna Choice POS II
    BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Health PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Pacificare HMO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: